Reducing skin damage from central line dressings
Part of Skin clinical trials.
This trial is testing whether a special medical adhesive and protective barrier can reduce skin damage (MARSI) from the dressing used to hold a central line in place. It is for adults in intensive care or the operating room who are getting a central line in their neck.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You need a central line (a special IV) placed into the internal jugular vein (in the neck).
- The skin where the line goes in is healthy and has no rashes or other problems.
- You do not have any known allergies to medical tape or barrier film used on the skin.
- You do not have a condition that causes excessive sweating (hyperhidrosis).
- You are not in isolation for a contagious skin or lung infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood clotting is activated in new central venous catheters (large IVs placed in a chest vein). It may help doctors understand and reduce clotting risks. You can join if you need a new catheter and are not on strong blood thinners.
This trial tests whether using a special skin/line “tissue glue” around IV line sites can lower the risk of bloodstream infections in critically ill children with heart disease. It may help reduce infection rates and line-related complications in children considered high risk.
This trial tests a new skin protectant lotion for people in the hospital with skin damage from moisture (like urine or stool). It aims to see if the lotion helps heal these wounds better than current care.
This trial studies how to make central lines safer by testing different ways to secure them and what caps to use. It is for people who need a central line, including those with cancer, and focuses on preventing infections.
This trial tests a special adhesive dressing made with zinc oxide to keep your IV line secure. It looks at whether this dressing helps prevent the line from moving, which could reduce complications.
This study tests a new approach to prevent infections on central venous catheters (thin tubes inserted into large veins) in hospital intensive care units. Researchers will study catheters that already show signs of bacterial growth to understand how to better protect patients from catheter-related infections.
Hear when a new Central Venous Catheter trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.